We’re pleased to announce initial findings at #ENDO2024 for our second clinical product candidate in two open-label studies for the treatment of Congenital Adrenal Hyperplasia and ACTH-dependent #CushingsSyndrome. Learn more: bit.ly/3VtV0Xj

At #ENDO2024 this past weekend, our Chief Commercial Officer, Jim Hassard, shared how Crinetics is addressing some of the most pressing challenges highlighted at this year's conference.

Our Chief Development Officer, Dana Pizzuti, MD, shares why #ENDO2024 is particularly exciting for Crinetics and highlights the encouraging strides we're making in our pipeline development.

June is #CAHAwarenessMonth. Congenital adrenal hyperplasia (CAH) is a family of genetic disorders affecting the body’s ability to produce cortisol. Learn how we’re committed to making difference in the lives of those with CAH: bit.ly/3XghDQx

In celebration of #PrideMonth, we hosted a dynamic, multi-perspective panel discussion where we focused on what being an #LGBTQ ally truly means. Thank you to all of our panelists for sharing your perspectives, and we look forward to putting these learnings into action.

We had the privilege of hosting a panel discussion in honor of #CAHAwarenessMonth. We were joined by the CARES Foundation and heard heartfelt stories from a patient and caregiver about how congenital adrenal hyperplasia has impacted their lives.

Excited to have our CEO & Founder, Scott Struthers, recognized as a winner in the Entrepreneur Of The Year® 2024 Pacific Southwest program! Scott’s visionary approach has earned him this prestigious honor: bit.ly/3xo5Y7x #EOYUS #EOYPACSW EY US

“The privilege to come to work each day and collaborate with such a fantastic, creative, and motivated team knowing that we are all working so hard to help people is what excites and inspires me the most about working at Crinetics.” – Michael Johns bit.ly/4bZ8noa

CAH affects 1 in 10,000-15,000 live births in the U.S. & Europe. Our Co-founder and Chief Scientific Officer, Steve Betz, emphasizes Crinetics' commitment to addressing the urgent need for effective CAH treatments. #CAHAwarenessMonth

As part of our commitment to improving care for #endocrine diseases, we launched AcromegalyTruth.com, a platform for HCPs that features research and patient perspectives on the challenges of treating #acromegaly. Explore the site: acromegalytruth.com

Endocrinology impacts almost every aspect of human health, and our world-class, in-house R&D organization continues to produce a deep pipeline of transformative candidates aimed at improving the lives of those affected by endocrine disorders. Learn More: bit.ly/3zqnbOt

For acromegaly patients on injectable somatostatin receptor ligands (SRLs), treatment-related symptoms and side effects can impair quality of life. Discover the truth about challenges faced by #acromegaly patients: acromegalytruth.com

Uncontrolled #acromegaly has a debilitating impact on daily functioning and quality of life. Learn about our product candidate in development for the treatment of acromegaly. bit.ly/4cTcdzP

We are excited to announce the launch of ACRO/TRUTH, a resource spotlighting the significant challenges and burdens people living with #acromegaly may experience when managing their disease with the standard-of-care treatment. Learn more: bit.ly/3YxHiEZ

#CRNX announces second quarter 2024 earnings. Learn more: bit.ly/3WxSWgm

Acromegaly patients face numerous challenges, and the burden of treatment is a significant one. For example, regular injections with large needles can often be painful and inconvenient. Learn more about this #acromegaly treatment burden: bit.ly/3SKQ4vw

At Crinetics, we believe patient-focused drug development is vital. From molecule to medicine, we value the patient’s voice and encourage patient input into our clinical development programs and beyond. Learn more about our patient advocacy efforts: crinetics.com/patients/

Acromegaly patients often endure breakthrough symptoms while undergoing treatment. These symptoms can have a debilitating impact on a patient's quality of life. Learn more about this #acromegaly treatment burden: acromegalytruth.com/#breakthroughs…

Living with acromegaly presents unique challenges that require understanding, compassion, and a strong support system. Hear from #acromegaly patients on the vital role of a strong support system: bit.ly/3YUZHM1

The current standard of care for treating #acromegaly can create an emotional impact on patients. It is important to recognize this impact and to account for the emotional needs of patients. Learn more: acromegalytruth.com/#emotionalimpa…